DHR250103P270000
- 0.00
- 0.000.00%
Danaher Newsroom
Danaher Analyst Ratings
Wells Fargo Spotlights 31 Names It Believes 'Offer Above-average Growth Potential'
Wolfe Research Adjusts Danaher's Price Target to $275 From $285, Keeps Outperform Rating
Citi Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $285
Express News | Danaher Corp : Citigroup Cuts Target Price to $285 From $305
Danaher (DHR) Receives a Buy From Citi
Danaher to Present at J.P. Morgan Healthcare Conference
After experiencing a bumper harvest in 2024, the USA ETF may encounter setbacks this year.
The USA Exchange Traded Fund (ETF) received a record inflow of $1.1 trillion in 2024, but entering 2025, rapid growth may face more obstacles.
Evercore Maintains Danaher(DHR.US) With Buy Rating, Cuts Target Price to $268
Danaher Schedules Fourth Quarter 2024 Earnings Conference Call
Should Weakness in Danaher Corporation's (NYSE:DHR) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Express News | The Danaher Northern China Joint Office has been launched in Peking, utilizing a shared workspace model.
Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years
14 Analysts Have This To Say About Danaher
Danaher Initiated at Sector Perform by Scotiabank
Scotiabank Initiates Danaher(DHR.US) With Hold Rating, Announces Target Price $265
Guggenheim Initiates Danaher(DHR.US) With Buy Rating, Announces Target Price $275
5 High-Flying Stocks In Dan Loeb's Portfolio: Cinemark, Corpay, Amazon Lead
Danaher, Cryoport, Sartorius Win Buy as Guggenheim Expands Bioprocessing Coverage
Guggenheim Initiates Danaher at Buy With $275 Price Target